KLEE JUSTIN B. (Co-Chief Executive Officer) sold 0.5% of their position (15.50K shares) of AMYLYX PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $227.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2026ACC: 0001193125-26-037544
DirectorOfficer· Co-Chief Executive Officer
Since Jan 2022
-15.50K
Net shares
Net seller
$227.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15.50K
Price / share
$14.69
Trade value
$227.62K
% of position
0.5%
2/2/2026
3.38M→3.36M
Total
Net shares
−15.50K
Net value
-$227.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −15.50K | $14.69 | $227.62K | 0.5% | 3.38M | 3.36M |
| Total | −15.50K | -$227.62K | ||||||
Derivative Transactions0
No derivative transactions reported